Abstract
SUMMARY: The specificity of selected immune responses to equine herpesvirus type 1 (ehv-1) and type 4 (ehv-4) was examined in 3 colostrum-deprived specific-pathogen-free foals. Single foals were vaccinated with inactivated ehv-1, inactivated ehv-4, or control cell lysate plus adjuvant followed by successive intranasal challenge exposures with ehv-1 and ehv-4 or with ehv-4 and ehv-1. Vaccination with inactivated virus preparations elicited cellular immune responses and antibody which were augmented by subsequent challenge exposures. Cellular immune responses, as measured by in vitro lymphocyte blastogenesis, were cross-reactive after foals were given either ehv-1 or ehv-4. Serum virus-neutralizing antibody responses were type-specific for foals given ehv-1, but were cross-reactive after ehv-4 administrations. It was concluded that diseases caused by ehv-1 and ehv-4 may be more effectively controlled with a bivalent vaccine containing both ehv-1 and ehv-4 than with the presently used monovalent vaccines based on ehv-1 alone.